AstraZeneca Says it Will Begin Profiting From its Vaccine

The drug maker AstraZeneca has been promoting its coronavirus vaccine at not-for-profit costs through the pandemic, as a part of a promise to rollout the vaccine at price by way of the disaster. However on Friday, the Anglo-Swiss firm mentioned in reporting its third-quarter earnings that it could start pricing its vaccine to make a